Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Vaginal Versus Intramuscular Progesterone for the Prevention of Recurrent Preterm Birth
NCT02913495Phase 4Completed
- Sponsor
- Thomas Jefferson University
- Start
- Sep 2016
- Primary completion
- Aug 2021
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised trial of progesterone in preterm birth (2 arms), sponsored by Thomas Jefferson University. Primary endpoint: Preterm Birth <37 Weeks up to 9 months. Started Sep 2016; status: completed.
02
Drugs
progesterone
03
Conditions
preterm birth
Beyond the preview
Go deeper on NCT02913495.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02913495.